1492 Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $213K | Buy |
+1,876
| New | +$213K | 0.1% | 107 |
|
|
2019
Q2 | – | Sell |
-12,880
| Closed | -$1.01M | – | 88 |
|
|
2019
Q1 | $1.01M | Sell |
12,880
-1,266
| -9% | -$99.3K | 0.86% | 39 |
|
|
2018
Q4 | $1.2M | Sell |
14,146
-1,078
| -7% | -$91.3K | 1.07% | 29 |
|
|
2018
Q3 | $2.61M | Sell |
15,224
-104
| -0.7% | -$17.8K | 1.7% | 22 |
|
|
2018
Q2 | $1.98M | Sell |
15,328
-240
| -2% | -$31K | 1.42% | 28 |
|
|
2018
Q1 | $1.6M | Hold |
15,568
| – | – | 1.23% | 29 |
|
|
2017
Q4 | $1.33M | Sell |
15,568
-125
| -0.8% | -$10.7K | 1.04% | 31 |
|
|
2017
Q3 | $1.33M | Sell |
15,693
-48
| -0.3% | -$4.08K | 1.18% | 29 |
|
|
2017
Q2 | $1.19M | Sell |
15,741
-392
| -2% | -$29.7K | 1.05% | 31 |
|
|
2017
Q1 | $1.07M | Hold |
16,133
| – | – | 0.83% | 38 |
|
|
2016
Q4 | $1.02M | Sell |
16,133
-23,181
| -59% | -$1.47M | 0.79% | 37 |
|
|
2016
Q3 | $2.5M | Buy |
39,314
+32,011
| +438% | +$2.04M | 2.05% | 20 |
|
|
2016
Q2 | $543K | Sell |
7,303
-736
| -9% | -$54.7K | 0.49% | 49 |
|
|
2016
Q1 | $537K | Sell |
8,039
-279
| -3% | -$18.6K | 0.45% | 54 |
|
|
2015
Q4 | $563K | Sell |
8,318
-758
| -8% | -$51.3K | 0.41% | 60 |
|
|
2015
Q3 | $485K | Buy |
+9,076
| New | +$485K | 0.35% | 74 |
|
|
2015
Q2 | – | Sell |
-94,739
| Closed | -$4.56M | – | 129 |
|
|
2015
Q1 | $4.56M | Buy |
94,739
+59,414
| +168% | +$2.86M | 2.64% | 8 |
|
|
2014
Q4 | $1.17M | Sell |
35,325
-549
| -2% | -$18.2K | 0.73% | 34 |
|
|
2014
Q3 | $1.05M | Sell |
35,874
-4,373
| -11% | -$128K | 0.58% | 40 |
|
|
2014
Q2 | $1.56M | Sell |
40,247
-1,022
| -2% | -$39.7K | 0.8% | 33 |
|
|
2014
Q1 | $1.73M | Buy |
41,269
+4,044
| +11% | +$170K | 0.86% | 33 |
|
|
2013
Q4 | $1.22M | Buy |
+37,225
| New | +$1.22M | 0.66% | 36 |
|